Reckitt Benckiser Group plc (FRA:3RB)

Blueprint Medicines Statistics

Total Valuation

FRA:3RB has a market cap or net worth of EUR 44.52 billion. The enterprise value is 54.32 billion.

Market Cap	44.52B
Enterprise Value	54.32B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Apr 10, 2025

Share Statistics

Current Share Class	679.03M
Shares Outstanding	n/a
Shares Change (YoY)	-3.69%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	672.40M

Valuation Ratios

The trailing PE ratio is 30.73 and the forward PE ratio is 15.89.

PE Ratio	30.73
Forward PE	15.89
PS Ratio	2.73
PB Ratio	6.01
P/TBV Ratio	n/a
P/FCF Ratio	18.09
P/OCF Ratio	15.19
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.88, with an EV/FCF ratio of 22.07.

EV / Earnings	37.49
EV / Sales	3.36
EV / EBITDA	12.88
EV / EBIT	14.37
EV / FCF	22.07

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 1.48.

Current Ratio	0.56
Quick Ratio	0.36
Debt / Equity	1.48
Debt / EBITDA	2.58
Debt / FCF	4.46
Interest Coverage	8.03

Financial Efficiency

Return on equity (ROE) is 17.37% and return on invested capital (ROIC) is 12.40%.

Return on Equity (ROE)	17.37%
Return on Assets (ROA)	8.01%
Return on Invested Capital (ROIC)	12.40%
Return on Capital Employed (ROCE)	20.61%
Revenue Per Employee	430,410
Profits Per Employee	38,230
Employee Count	37,900
Asset Turnover	0.55
Inventory Turnover	3.42

Taxes

In the past 12 months, FRA:3RB has paid 753.62 million in taxes.

Income Tax	753.62M
Effective Tax Rate	34.00%

Stock Price Statistics

The stock price has increased by +28.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.75%
50-Day Moving Average	59.90
200-Day Moving Average	59.54
Relative Strength Index (RSI)	69.64
Average Volume (20 Days)	532

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3RB had revenue of EUR 16.31 billion and earned 1.45 billion in profits. Earnings per share was 2.10.

Revenue	16.31B
Gross Profit	9.93B
Operating Income	3.81B
Pretax Income	2.22B
Net Income	1.45B
EBITDA	4.16B
EBIT	3.81B
Earnings Per Share (EPS)	2.10

Balance Sheet

The company has 1.12 billion in cash and 10.97 billion in debt, giving a net cash position of -9.84 billion.

Cash & Cash Equivalents	1.12B
Total Debt	10.97B
Net Cash	-9.84B
Net Cash Per Share	n/a
Equity (Book Value)	7.41B
Book Value Per Share	10.84
Working Capital	-4.53B

Cash Flow

In the last 12 months, operating cash flow was 2.93 billion and capital expenditures -468.97 million, giving a free cash flow of 2.46 billion.

Operating Cash Flow	2.93B
Capital Expenditures	-468.97M
Free Cash Flow	2.46B
FCF Per Share	n/a

Margins

Gross margin is 60.89%, with operating and profit margins of 23.38% and 8.88%.

Gross Margin	60.89%
Operating Margin	23.38%
Pretax Margin	13.59%
Profit Margin	8.88%
EBITDA Margin	25.49%
EBIT Margin	23.38%
FCF Margin	15.09%

Dividends & Yields

This stock pays an annual dividend of 2.36, which amounts to a dividend yield of 3.63%.

Dividend Per Share	2.36
Dividend Yield	3.63%
Dividend Growth (YoY)	5.29%
Years of Dividend Growth	8
Payout Ratio	112.00%
Buyback Yield	3.69%
Shareholder Yield	7.32%
Earnings Yield	3.25%
FCF Yield	5.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:3RB has an Altman Z-Score of 3.16 and a Piotroski F-Score of 7.

Altman Z-Score	3.16
Piotroski F-Score	7